OECI POSSIBLE EVOLUTION WITHIN THE MISSION EUROPE

Size: px
Start display at page:

Download "OECI POSSIBLE EVOLUTION WITHIN THE MISSION EUROPE"

Transcription

1 OECI POSSIBLE EVOLUTION WITHIN THE MISSION EUROPE Thierry PHILIP President OECI October 3rd 2018, afternoon 1

2 OECI POSSIBLE EVOLUTION WITHIN THE MISSION EUROPE OECI EUROPEAN CANCER CENTRES France Belgium Italie Netherlands etc OECI European cancer Centres France OECI European cancer Centres Belgium OECI European cancer Centres Italie OECI European cancer Centres Netherlands 2

3 MEMBERS OF THE OECI MISSION Comprehensive Cancer Centres Clinical Cancers Centres All members are Associate Members to the Mission only in the case they are engaged to enter the Accreditation and Designation Programme in the next 3 years or they will at least apply. They become Member when Designated CCC or ClCC 3

4 TO DO WHAT? 1) Improve quality Chair : Simon OBERST Improvement plan exchange of experience. Use of minimal requirement in organ clinic if modified to be coherent with an accreditation process (auto-evaluation) (in cooperation with START?) Work on Version 3.0 Work on re-accreditation process. 4

5 Working with the German Society on the process of designation of clinics and with EACS on the process of translational research. To produce position papers. To imply patients in the process. 5

6 Comprehensive Cancer Centrs Or Clinical Cancer Centres Add Clinics by secondarily Add Network secondarily or Designation of excellence for Translational research Cancer Aid, EACS DoE 6

7 TO DO WHAT? 2) Produce outcome data in real life OECI Outcome Cancer Research WG Chair: Milena Sant OECI Health Economics WG Chair: Wim H. van Harten With as Conductors of the evolution: Giovanni Apolone and Jean-Yves Blay 7

8 TO DO WHAT? 3)To mobilise patients and citizens to support quality improvement and innovations in cancer care and research OECI Collaboration for Good Practices with Patients WG Chair: Dominique de Valeriola Coordination: Patrick Miqueau With the support of the ECPC: Francesco De Lorenzo 8

9 OECI AND A PUTATIVE EUROPEAN MISSION Thierry PHILIP President OECI October 3rd 2018, afternoon 9

10 ALTERNATIVE To play a role within Cancer Core Europe proposal To propose an alternative ie: OECI proposal for a Cancer Mission 10

11 BIG IDEA? BIG CHALLENGE? BIG PLAN? 11

12 BIG IDEA To translate new drugs to earlier stage of cancer Early detection of cancers and their relapses in the European population with emphasis in aging Early detection of cancer that we don t know how to cure currently (lung, pancreas, brain...) Prevention and early detection of cancer Preventing and targeting cancer epidemy To set-up a cancer registry for patients outcomes comparision in a network of 100 cancer centres A mission on pediatric cancer Quality in cancer care Hope in cancer Reduce inequqlities and lift up less well performing regions or countries To improve outcomes for all cancer patients in Europe through multidisciplinarity 12

13 BIG IDEA: true integrative care in cancer Institutional research of quality from doctors to technicians No loss of chances anywhere the patients knock on the door BIG CHALLENGE Networks around CCCs To build a European cancer ecosystem PLAN To define at least one CCC / Country To identify one network each 5 to 10 Millions inhabitants 14

14 WE NEED TO ADD: Rare cancers (including pediatrics?) Tumours that are not yet cured Early diagnosis of primary tumours and relapses Outcomes research Governance proposals and financial issues (more to those who get less today) Research on prevention THE ABOVE CHAPTERS COULD BE PILOT STUDIES TO BE IMPLEMENTED WITHIN THE NETWORKS AROUND CCCs True integrative care in cancer with 6 or 7 Work Packages? 15

15 TO SET-UP A BRAINSTORMING BEFORE CHRISTMAS ON THIS PROPOSAL? TO DISCUSS WITH CCE AT THE VATICAN MEETING TO TAKE A DECISION EARLY BEFORE THE OECI 2019 ONCOLOGY DAYS IN BARI (with or w/o CCE) 16

OECI accreditation: is yours a top-class cancer centre?

OECI accreditation: is yours a top-class cancer centre? OECI accreditation: is yours a top-class cancer centre? Whether you work at a cancer unit, a cancer centre or a comprehensive cancer centre, applying for OECI accreditation is a good way to find out how

More information

Towards quality, comprehensiveness and excellence. The accreditation project of the Organisation of European Cancer Institutes (OECI)

Towards quality, comprehensiveness and excellence. The accreditation project of the Organisation of European Cancer Institutes (OECI) Tumori, 94: 164-171, 2008 Towards quality, comprehensiveness and excellence. The accreditation project of the Organisation of European Cancer Institutes (OECI) Mahasti Saghatchian 1, Henk Hummel 2, Renée

More information

Jules Bordet Institute, Brussels, Belgium Université Libre de Bruxelles Breast International Group (BIG aisbl), Chair ESMO President

Jules Bordet Institute, Brussels, Belgium Université Libre de Bruxelles Breast International Group (BIG aisbl), Chair ESMO President Symposium «Evaluation of the Belgian Cancer Plan» Brussels, November 26th, 2012 Personalized oncology in Europe: only a dream if national health systems do not get involved in diagnostics and pivotal cancer

More information

COMMISSION OF THE EUROPEAN COMMUNITIES

COMMISSION OF THE EUROPEAN COMMUNITIES COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 22.12.2008 COM(2008) 882 final REPORT FROM THE COMMISSION TO THE COUNCIL, THE EUROPEAN PARLIAMENT, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE

More information

OECI EUROPEAN MISSION WORKING PARTY: B&MP VIEW

OECI EUROPEAN MISSION WORKING PARTY: B&MP VIEW BIOBANKING AND MOLECULAR PATHOBIOLOGY WG OECI EUROPEAN MISSION WORKING PARTY: B&MP VIEW Bruxelles 3 October 2018 Marco Pierotti & Giorgio Stanta CANCER AT MOLECULAR LEVEL STATEMENT 1 : Cancer is a disease

More information

The European Year of Volunteering 2011 What a Difference a Year Makes

The European Year of Volunteering 2011 What a Difference a Year Makes SPEECH/11/848 Kristalina Georgieva European Commissioner for International Cooperation, Humanitarian Aid and Crisis Response The European Year of Volunteering 2011 What a Difference a Year Makes Closing

More information

ESMO FELLOWSHIP PROGRAMME & LEADERS GENERATION PROGRAMME

ESMO FELLOWSHIP PROGRAMME & LEADERS GENERATION PROGRAMME ESMO FELLOWSHIP PROGRAMME & LEADERS GENERATION PROGRAMME Christoph Zielinski Chair of the ESMO Fellowship & Award Committee esmo.org ESMO FELLOWSHIP PROGRAMME Exclusive to ESMO members under 40 years old

More information

European Partnership for Screening

European Partnership for Screening European Partnership for Screening Lawrence von Karsa Quality Assurance Group European Cancer Network for Screening and Prevention International Agency for Research on Cancer Lyon, France Work Package

More information

OECI, Brussels Oct Health Technology Assessment and Health Economics. Prof Wim H. van Harten Valesca P. Retel

OECI, Brussels Oct Health Technology Assessment and Health Economics. Prof Wim H. van Harten Valesca P. Retel OECI, Brussels Oct 3 2018 Health Technology Assessment and Health Economics Prof Wim H. van Harten Valesca P. Retel High Medicines Pricing an International Issue Financial limitations (survey 2016) In

More information

OPEN FORUM ROME 19 & 20 June 2012

OPEN FORUM ROME 19 & 20 June 2012 Joint Action OPEN FORUM ROME 19 & 20 June 2012 Spotlight on Health Promotion & Prevention and Cancer Data & Information (Work Packages 5 & 9) Hosted by the Italian Ministry of Health, Rome, Italy This

More information

Outcome from the Joint Action on Cancer Control CanCon

Outcome from the Joint Action on Cancer Control CanCon Outcome from the Joint Action on Cancer Control CanCon Contributions and recommendations to the EU and national policies on cancer Tit Albreht ECPC Brussels 17 June 2017 Estimated change in the number

More information

Paolo G. Casali Annalisa Trama

Paolo G. Casali Annalisa Trama Paolo G. Casali Annalisa Trama Objectives With regard to RCs in the EU, to improve: 1. Epidemiological surveillance 2. Quality of care through ERNs 3. Clinical practice guidelines 4. Innovation 5. Medical

More information

Center for Cell Therapy and Regenerative Medicine (CCRG)

Center for Cell Therapy and Regenerative Medicine (CCRG) Center for Cell Therapy and Regenerative Medicine (CCRG) What is CCRG? CCRG is a multidisciplinary platform for new types of cellular therapy and tissue therapy. It is located on the campus of the Antwerp

More information

Annals of Oncology Advance Access published July 10, 2014

Annals of Oncology Advance Access published July 10, 2014 Annals of Oncology Advance Access published July 10, 2014 1 Still a long way to go to achieve multidisciplinarity for the benefit of patients: commentary on the ESMO position paper (Annals Oncology Jan;25(1):

More information

Pfizer Support to European and International Patient Organisations based in Belgium & Luxembourg in 2016

Pfizer Support to European and International Patient Organisations based in Belgium & Luxembourg in 2016 Pfizer Support to European and International Patient Organisations based in Belgium & Luxembourg in 2016 Please note that all information in this document is also disclosed in the overall report on Pfizer

More information

Irish Experts Launch Global Report and Call for Increased Focus on Metastatic Breast Cancer

Irish Experts Launch Global Report and Call for Increased Focus on Metastatic Breast Cancer Irish Experts Launch Global Report and Call for Increased Focus on Metastatic Breast Cancer Early detection does not help survival for metastatic breast cancer patients - average survival for women with

More information

Introduction. Paolo G. Casali

Introduction. Paolo G. Casali Introduction Paolo G. Casali paolo.casali@istitutotumori.mi.it rare diseases rare diseases rare cancers cancer rare cancers Rare cancers childhood Rare cancers childhood haematological Rare cancers childhood

More information

Introduction and illustration of the OECI study proposal/feedback of the survey on outcome studies Milena Sant, MD

Introduction and illustration of the OECI study proposal/feedback of the survey on outcome studies Milena Sant, MD Introduction and illustration of the OECI study proposal/feedback of the survey on outcome studies Milena Sant, MD Analytical Epidemiology and Health Impact Unit Department of Preventive and Predictive

More information

Cancer drug costs and payment issues in European countries.

Cancer drug costs and payment issues in European countries. Cancer drug costs and payment issues in European countries. Wim van Harten MD PhD, Riin Ots, Valesca Retel PhD, Anke Wind MSc. ECPC June 2017 Affiliations: The Netherlands Cancer Institute; University

More information

DEMENTIA: IMPLEMENTATION REPORT AND CURRENT DEVELOPMENTS EU HEALTH

DEMENTIA: IMPLEMENTATION REPORT AND CURRENT DEVELOPMENTS EU HEALTH DEMENTIA: IMPLEMENTATION REPORT AND CURRENT DEVELOPMENTS EU HEALTH Brussels, 19 March 2015 Michael Hübel Programme Management and Diseases Directorate-General for Health and Food Safety European Commission

More information

4nd Patient and Family Day

4nd Patient and Family Day 4nd Patient and Family Day EBMT Slide template Barcelona 7 February 2008 EBMT 2010 Vienna, Austria ; www.ebmt.org History of Stem Cell Transplantation Appelbaum et al, NEJM 2006 What is EBMT? Scientific,

More information

EXCELLENCE AND INNOVATION

EXCELLENCE AND INNOVATION EXCELLENCE AND INNOVATION FOR CANCER TREATMENT THE CENTRE LÉON BÉRARD Non-profit private health care facility of public interest (ESPIC), affiliated with the French National Cancer Center Federation UNICANCER

More information

Quality and Safety Initiatives for Radiation Oncology in Europe: different approaches, united view.

Quality and Safety Initiatives for Radiation Oncology in Europe: different approaches, united view. Quality and Safety Initiatives for Radiation Oncology in Europe: different approaches, united view. Yolande Lievens, MD, PhD Chair Radiation Oncology Department, Ghent University Hospital Co-Chair HERO

More information

Translating from bench- to bedside: vitamin D in multiple sclerosis

Translating from bench- to bedside: vitamin D in multiple sclerosis Valorisation Introduction In the final chapter of this thesis, we will elaborate on how to make the knowledge, obtained in our scientific research and reported in this thesis, work. What can our results

More information

Haematopoietic stem cell transplantation (SCT)

Haematopoietic stem cell transplantation (SCT) HAEMATOPOIETIC TEM CELL TRANPLANTATION FOR CHILREN IN BELGIUM Marie-Françoise resse 1 & Yves Beguin 2 1 epartment of Paediatrics, ivision of Hemato-Oncology, UHOPL, University of Liege, Liège, Belgium;

More information

ASCO Quality Oncology Practice Initiative (QOPI): Implications For A Rapid Learning System For Cancer

ASCO Quality Oncology Practice Initiative (QOPI): Implications For A Rapid Learning System For Cancer ASCO Quality Oncology Practice Initiative (QOPI): Implications For A Rapid Learning System For Cancer Joseph Jacobson, MD Chair, QOPI Steering Committee Salem MA October 6, 2009 American Society of Clinical

More information

Joint Programming in Neurodegenerative Disease Research (JPND)

Joint Programming in Neurodegenerative Disease Research (JPND) Joint Programming in Neurodegenerative Disease Research (JPND) Building Alliances and Collaborations Prof. Philippe Amouyel, MD, PhD JPND Chair France Disclosure CEO of Fondation Plan Alzheimer Conference

More information

PHOTO. VHPB/ELPA MEETING Prevention and Control of Viral Hepatitis The role and impact of patients and advocacy groups in and outside Europe

PHOTO. VHPB/ELPA MEETING Prevention and Control of Viral Hepatitis The role and impact of patients and advocacy groups in and outside Europe www.eurordis.org VHPB/ELPA MEETING Prevention and Control of Viral Hepatitis The role and impact of patients and advocacy groups in and outside Europe Lucca ( Italy ) March 13-14, 2008 PHOTO www.eurordis.org

More information

IARC A UNIQUE AGENCY. Cancer research for cancer prevention

IARC A UNIQUE AGENCY. Cancer research for cancer prevention IARC A UNIQUE AGENCY Cancer research for cancer prevention Director s message IARC is a unique organization. For the past 50 years, the Agency has been making important contributions to the global fight

More information

A pan European Dementia Strategy

A pan European Dementia Strategy A pan European Dementia Strategy Luxembourg 13 June 2017 Vanessa Challinor, Policy Officer @vanessachall Agenda Alzheimer Europe Campaign to recognise dementia as policy and research priority National

More information

CYPRUS PRESIDENCY OF THE COUNCIL OF THE EU

CYPRUS PRESIDENCY OF THE COUNCIL OF THE EU CYPRUS PRESIDENCY OF THE COUNCIL OF THE EU July December 2012 Research Symposium on Digestive and Liver Diseases Brussels, 18 September 2012 Dr Myrto Azina- Chronides Ministry of Health Cyprus Digestive

More information

NEWS. n. 2 - December 2016

NEWS. n. 2 - December 2016 NEWS n. 2 - December 2016 Organisation of European Cancer Institutes European Economic Interest Grouping - RPM n. 0473647634 Message from the President Relationship with cancer Organisations We want your

More information

Making dementia a European priority

Making dementia a European priority Making dementia a European priority Glasgow 1 June 2015 Jean Georges, Executive Director Alzheimer Europe 36 associations in 31 countries 2 Paris Declaration Adopted by Annual General Meeting in Paris

More information

9th INTERNATIONAL NICE September, 2018 Milan, Italy. Islet - beta cell. replacement

9th INTERNATIONAL NICE September, 2018 Milan, Italy. Islet - beta cell. replacement 9th INTERNATIONAL 24-26 September, 2018 Milan, Italy 9th INTERNATIONAL AIM OF THE MEETING The aim of this workshop is to provide theoretical education and practical training to scientists, physicians,

More information

Table Of Content. A European Network of Centres of Reference for Dysmorphology... 2 Summary... 3 Coordinator, Leader contact and partners...

Table Of Content. A European Network of Centres of Reference for Dysmorphology... 2 Summary... 3 Coordinator, Leader contact and partners... Table Of Content A European Network of Centres of Reference for Dysmorphology... 2 Summary... 3 Coordinator, Leader contact and partners... 4 The Children's Memorial Health Institute IPCZD... 4 Katholieke

More information

Where we stand in EFORT

Where we stand in EFORT Where we stand in EFORT Engaging with the new EU regulatory landscape for medical devices. Challenges & opportunities Brussel, Belgium April 6, 2018 Per Kjaersgaard-Andersen Associate Professor Section

More information

Organisation of European Cancer Institutes European Economic Interest Grouping. Magazine. Number 1 - Year 2 May 2018

Organisation of European Cancer Institutes European Economic Interest Grouping. Magazine. Number 1 - Year 2 May 2018 Organisation of European Cancer Institutes European Economic Interest Grouping Magazine Number 1 - Year 2 May 2018 In memory of our dear Thomas On behalf of the OECI Mahasti Saghatchian Gustave Roussy

More information

Workshop 2 Active & Healthy Ageing: Pain management for an improved quality of life

Workshop 2 Active & Healthy Ageing: Pain management for an improved quality of life Workshop 2 Active & Healthy Ageing: Pain management for an improved quality of life Per Kjaersgaard-Andersen, MD, Ass proff Secretary General EFORT European Federation of National Associations of Orthopaedics

More information

8th Meet The Professor. Advanced International Breast Cancer Course (AIBCC)

8th Meet The Professor. Advanced International Breast Cancer Course (AIBCC) Sezione di Oncologia [ Meet the Professor ] 8th Meet The Professor. Advanced International Breast Cancer Course (AIBCC) November 15-17, 2012 The Conference will include: 1) Lectures: Internationally recognized

More information

General Assembly A new phase for paediatric clinical research: a role play for TEDDY? January 14 th, 2018 Hotel Ripa Via degli Orti di Trastevere, 3

General Assembly A new phase for paediatric clinical research: a role play for TEDDY? January 14 th, 2018 Hotel Ripa Via degli Orti di Trastevere, 3 General Assembly A new phase for paediatric clinical research: a role play for TEDDY? January 14 th, 2018 Hotel Ripa Via degli Orti di Trastevere, 3 Rome - Italy The TEDDY Network of Excellence arose from

More information

RESPECT Project CASE STUDY

RESPECT Project CASE STUDY CASE STUDY RESPECT Project RESPECT aims to provide vulnerable and disadvantaged families with support that will promote positive relationships and a stable family structure through regular and consistent

More information

SPONSORSHIP OPPORTUNITIES

SPONSORSHIP OPPORTUNITIES CONFERENCES SPONSORSHIP OPPORTUNITIES International Conference on n Biomarkers and Cancer Targets December 05-06, 2018 Dubai, UAE our DELEGATE is your CLIENT Our Programme 5+ Keynote Sessions Our programme

More information

COUNCIL RECOMMENDATION of 2 December 2003 on cancer screening (2003/878/EC)

COUNCIL RECOMMENDATION of 2 December 2003 on cancer screening (2003/878/EC) L 327/34 COUNCIL RECOMMDATION of 2 December 2003 on cancer screening (2003/878/EC) THE COUNCIL OF THE EUROPEAN UNION, Having regard to the Treaty establishing the European Community, and in particular

More information

ECPC ANNUAL CONGRESS ECPC GENERAL ASSEMBLY

ECPC ANNUAL CONGRESS ECPC GENERAL ASSEMBLY ECPC ANNUAL CONGRESS FRIDAY 8 SATURDAY 9 JUNE 2018 & ECPC GENERAL ASSEMBLY SUNDAY 10 JUNE 2018 VENUE: RENAISSANCE BRUSSELS HOTEL, RUE DU PARNASSE 19, 1050 BRUXELLES EVENT ORGANISED UNDER THE HIGH PATRONAGE

More information

On behalf of E-PILEPSY consortium Philippe Ryvlin (Lyon, France)

On behalf of E-PILEPSY consortium Philippe Ryvlin (Lyon, France) A European pilot network of reference centres in refractory epilepsy and epilepsy surgery On behalf of E-PILEPSY consortium Philippe Ryvlin (Lyon, France) Brussels, Written Declaration on Epilepsy! 6.000.000

More information

SPONSORSHIP OPPORTUNITIES

SPONSORSHIP OPPORTUNITIES CONFERENCES SPONSORSHIP OPPORTUNITIES 2 nd Head and Neck Conference: The Multidisciplinary Approach December 05-06, 2019 Abu Dhabi, UAE our DELEGATE is your CLIENT Our Programme 5+ Keynote Sessions Our

More information

1-2 December 2015 Geneva, Switzerland. Anticipating emerging infectious disease epidemics

1-2 December 2015 Geneva, Switzerland. Anticipating emerging infectious disease epidemics 1-2 December 2015 Geneva, Switzerland Anticipating emerging infectious disease epidemics Session 1 Summary of the meeting Session 1: learning from the past (1) Preparedness (inter-epidemic period) is a

More information

Professor Eric Félix Lartigau

Professor Eric Félix Lartigau 2016 The Future of Hospitals and Healthcare Professor Eric Félix Lartigau General Director Centre Oscar Lambret Former Secretary of ESTRO How future trends in Oncology may impact hospital organisation

More information

April 26 th. Cancer survivorship: worldwide scenario Chairs: A. Paradiso, Sophie D. Fosså

April 26 th. Cancer survivorship: worldwide scenario Chairs: A. Paradiso, Sophie D. Fosså NATIONAL CANCER RESEARCH CENTRE GIOVANNI PAOLO II Viale Orazio Flacco 65, 70124 Bari Italy website: www.oncologico.bari.it THE NETHERLANDS CANCER INSTITUTE NKI AVL Plesmanlaan, 121 1066 CX Amsterdam The

More information

The power of innovation to save lives

The power of innovation to save lives Innovative Finance The power of innovation to save lives May 2013 The challenge Life or death for a young child too often depends on whether he is born in a country where vaccines are available or not.

More information

EuropaColon Uniting citizens in the fight against colorectal cancer. Zorana Maravic Director of Group Development May, 2013

EuropaColon Uniting citizens in the fight against colorectal cancer. Zorana Maravic Director of Group Development May, 2013 EuropaColon Uniting citizens in the fight against colorectal cancer Zorana Maravic Director of Group Development May, 2013 Colorectal cancer in Europe today >450,000 new diagnoses every year 2nd most common

More information

& FIGUREs Netherlands Cancer Institute

& FIGUREs Netherlands Cancer Institute Facts & FIGUREs 2014-2015 Netherlands Cancer Institute Comprehensive Cancer CentRE Research institute (The Netherlands Cancer Institute) Specialised clinic (Antoni van Leeuwenhoek hospital) Netherlands

More information

EPAG UPDATE. Lenja Wiehe. European Patient Advocacy Groups Manager, EURORDIS

EPAG UPDATE. Lenja Wiehe. European Patient Advocacy Groups Manager, EURORDIS EPAG UPDATE Lenja Wiehe European Patient Advocacy Groups Manager, EURORDIS Patient Centre & Empowerment European Reference Networks (ERNs) created on founding principles of patient-centred care, patient

More information

Transforming health through IT

Transforming health through IT @himsseurope HIMSS Europe 02 HIMSS Europe www.himss.eu The Leading Health IT Knowledge Organisation HIMSS Europe is a voice, advisor and thought leader of transformation through health IT. As an independent

More information

Type 1 Diabetes Australian Research Impact Analysis

Type 1 Diabetes Australian Research Impact Analysis Type 1 Diabetes Australian Research Impact Analysis Executive Overview Summary Type 1 diabetes research in Australia Australia is making a significant contribution to the quantity and quality of the global

More information

The National Pancreas Foundation. Volunteering Policy & Engagement Procedure

The National Pancreas Foundation. Volunteering Policy & Engagement Procedure INTRODUCTION & BACKGROUND The National Pancreas Foundation The National Pancreas Foundation s (the NPF) recruitment and deployment of volunteers is predominantly in our Chapters Program. Chapters are a

More information

Gesundheit in Horizont 2020

Gesundheit in Horizont 2020 Wien, 5, Dezember 2013 Gesundheit in Horizont 2020 Gesellschaftliche Herausforderung 1: Gesundheit, demografischer Wandel und Wohlergehen Dr Elmar Nimmesgern GD Forschung und Innovation Europäische Kommission

More information

Translational Research in Oncology in the Era of Personalized Medicine and Open Science: Are the Current Funding Mechanisms Fit for Purpose?

Translational Research in Oncology in the Era of Personalized Medicine and Open Science: Are the Current Funding Mechanisms Fit for Purpose? Policy Brief Draft- Funding mechanisms: a case study on Translational Oncology Julio E. Celis Member of RISE Dainius Pavalkis Member of RISE This document has been prepared for the European Commission

More information

Quality and Safety of HSCT in Autoimmune Diseases

Quality and Safety of HSCT in Autoimmune Diseases Quality and Safety of HSCT in Autoimmune Diseases Dr John Snowden Stem Cell Transplant Programme Director Sheffield Teaching Hospitals and University of Sheffield & JACIE Medical Director 1 HSCT is GROWING

More information

Rare Cancer Perspective in the EUCERD

Rare Cancer Perspective in the EUCERD EURORDIS' activities on EU and National Policies Rare Cancer Perspective in the EUCERD Jan Geissler Alternate Member, EU Committee of Experts for Rare Diseases (EUCERD) Director, European Patients Academy

More information

BOOSTING THE SOCIAL IMPACT OF INNOVATIVE CANCER RESEARCH

BOOSTING THE SOCIAL IMPACT OF INNOVATIVE CANCER RESEARCH The Pontifical Academy of Sciences Workshop on A MISSION-ORIENTED APPROACH TO CANCER IN EUROPE: BOOSTING THE SOCIAL IMPACT OF INNOVATIVE CANCER RESEARCH 16-17 November 2018 Casina Pio IV Vatican City Organized

More information

Table Of Content. Information network on rare cancers... 2 Summary... 3 Coordinator, Leader contact and partners Outputs...

Table Of Content. Information network on rare cancers... 2 Summary... 3 Coordinator, Leader contact and partners Outputs... Table Of Content Information network on rare cancers... 2 Summary... 3 Coordinator, Leader contact and partners... 5 National University Specialised Hospital for Active Treatment in Oncology - NOH... 5

More information

CURRICULUM VITAE. József Lövey M.D. Ph.D.

CURRICULUM VITAE. József Lövey M.D. Ph.D. CURRICULUM VITAE József Lövey M.D. Ph.D. Personal Data Name József Lövey Address 5, Mester u. Pilisborosjenő 2097 Hungary Phone (361)-1-224-8600 Fax (361)-1-224-8620 e-mail lovey@oncol.hu Nationality Hungarian

More information

1. The Working Party on Public Health discussed and agreed the draft Council conclusions as set out in the Annex.

1. The Working Party on Public Health discussed and agreed the draft Council conclusions as set out in the Annex. Council of the European Union Brussels, 26 November 2015 (OR. en) 14395/15 SAN 391 NOTE From: To: Subject: General Secretariat of the Council Permanent Representatives Committee/Council Employment, Social

More information

SPONSORSHIP OPPORTUNITIES

SPONSORSHIP OPPORTUNITIES CONFERENCES SPONSORSHIP OPPORTUNITIES 2 nd Global Meeting on Diabetes and Endocrinology May 30-31, 2019 Istanbul, Turkey our DELEGATE is your CLIENT Our Programme 5+ Keynote Sessions Our programme aims

More information

Towards Integrated Syndromic Surveillance in Europe?

Towards Integrated Syndromic Surveillance in Europe? Towards Integrated Syndromic Surveillance in Europe? Duncan Cooper - Born in Bradford Research Study, UK Triple-S partners including Anette Hulth, Alexandra Ziemann, Jean-Babtiste Perrin, Mark Kanieff,

More information

Acquired Drivers of Disaese ahus and autoantibodies: their role in disease and their impact on patient management

Acquired Drivers of Disaese ahus and autoantibodies: their role in disease and their impact on patient management Acquired Drivers of Disaese ahus and autoantibodies: their role in disease and their impact on patient management Veronique Fremeaux-Bacchi Cordeliers Research Center and Européen Georges Pompidou Hospital,

More information

EUROPEAN GUIDE ON QUALITY IMPROVEMENT IN COMPREHENSIVE CANCER CONTROL

EUROPEAN GUIDE ON QUALITY IMPROVEMENT IN COMPREHENSIVE CANCER CONTROL EUROPEAN GUIDE ON QUALITY IMPROVEMENT IN COMPREHENSIVE CANCER CONTROL Policy Paper on National Cancer Control Programmes (NCCPs)/ Cancer Documents in Europe Marjetka Jelenc, Tit Albreht, Karen Budewig,

More information

39th SESSION OF THE SUBCOMMITTEE ON PLANNING AND PROGRAMMING OF THE EXECUTIVE COMMITTEE

39th SESSION OF THE SUBCOMMITTEE ON PLANNING AND PROGRAMMING OF THE EXECUTIVE COMMITTEE PAN AMERICAN HEALTH ORGANIZATION WORLD HEALTH ORGANIZATION 39th SESSION OF THE SUBCOMMITTEE ON PLANNING AND PROGRAMMING OF THE EXECUTIVE COMMITTEE Washington, D.C., USA, 16-18 March 2005 Provisional Agenda

More information

Heidelberg Ion-Beam Therapy Centre (HIT) officially opened

Heidelberg Ion-Beam Therapy Centre (HIT) officially opened Powered by Website address: https://www.gesundheitsindustrie-bw.de/en/article/pressrelease/heidelberg-ion-beam-therapy-centre-hit-officiallyopened/ Heidelberg Ion-Beam Therapy Centre (HIT) officially opened

More information

EXPERT CONSULTATION ON UNLOCKING GLOBAL COLLABORATION TO ACCELERATE INNOVATION FOR ALZHEIMER S DISEASE AND DEMENTIA.

EXPERT CONSULTATION ON UNLOCKING GLOBAL COLLABORATION TO ACCELERATE INNOVATION FOR ALZHEIMER S DISEASE AND DEMENTIA. EXPERT CONSULTATION ON UNLOCKING GLOBAL COLLABORATION TO ACCELERATE INNOVATION FOR ALZHEIMER S DISEASE AND DEMENTIA 20-21 June, 2013 The Harris Manchester College Oxford, United Kingdom Background The

More information

Progress Report of the activities of the Working Group «Hypertension and the Kidney»

Progress Report of the activities of the Working Group «Hypertension and the Kidney» Progress Report of the activities of the Working Group «Hypertension and the Kidney» 2015-2016 Contents List of members of the WG... 2 Statutes... 2 WG meetings and proceedings... 2 European Fibromuscular

More information

GERIATRIC TEACHING AND TRAINING IN EUROPE: Where are we? (part I)

GERIATRIC TEACHING AND TRAINING IN EUROPE: Where are we? (part I) GERIATRIC TEACHING AND TRAINING IN EUROPE: Where are we? (part I) Pr. Olivier Beauchet, MD, PhD Department of Neuroscience Geriatrics Division and Memory Clinic Angers University Hospital and School of

More information

Clinical Evidence in the Daily Work of an Anthroposophic Hospital Dr. med. Harald Matthes, Medical Director, Havelhöhe Hospital in Berlin

Clinical Evidence in the Daily Work of an Anthroposophic Hospital Dr. med. Harald Matthes, Medical Director, Havelhöhe Hospital in Berlin Programme Venue: Time: Chair: Presentations: Members Salon, European Parliament 8:00 9:30 am Marian Harkin MEP Research Evidence in Homeopathy: Overview of published clinical investigations Robert Mathie

More information

INNOVATIVE PARTNERSHIP FOR ACTION AGAINST CANCER (ipaac) Official ipaac Joint Action presentation

INNOVATIVE PARTNERSHIP FOR ACTION AGAINST CANCER (ipaac) Official ipaac Joint Action presentation INNOVATIVE PARTNERSHIP FOR ACTION AGAINST CANCER (ipaac) GENERAL INFORMATION The Innovative Partnership for Action Against Cancer (ipaac) Joint Action, which has been selected for funding under the Third

More information

Cancer Control in Developing Countries

Cancer Control in Developing Countries 2003 Cancer Control in Developing Countries Annual Meeting Brussels May 29-31 Mission Statement The is dedicated to helping build capacity for cancer treatment and research in countries in which such capacity

More information

ROLE SPECIFICATION FOR MACMILLAN GPs

ROLE SPECIFICATION FOR MACMILLAN GPs ROLE SPECIFICATION FOR MACMILLAN GPs November 2010 History of Macmillan GPs Macmillan Cancer Support has funded GP positions from the early 1990 s, following the success of our investment in supporting

More information

JPI A healthy diet for a healthy life. JPI: concept and benefits Vision Research areas Governance

JPI A healthy diet for a healthy life. JPI: concept and benefits Vision Research areas Governance JPI A healthy diet for a healthy life JPI: concept and benefits Vision Research areas Governance European research area Today, 85% of public R&D is programmed, financed, monitored and evaluated at national

More information

ESTS SCHOOL FIRST ESTS-ERS COLLABORATIVE COURSE ON THORACIC ONCOLOGY A MULTIDISCIPLINARY UPDATE ON POTENTIALLY OPERABLE LUNG CANCER

ESTS SCHOOL FIRST ESTS-ERS COLLABORATIVE COURSE ON THORACIC ONCOLOGY A MULTIDISCIPLINARY UPDATE ON POTENTIALLY OPERABLE LUNG CANCER SCHOOL FIRST -ERS COLLABORATIVE COURSE ON ONCOLOGY A MULTIDISCIPLINARY UPDATE ON POTENTIALLY OPERABLE LUNG CANCER 11-13 February 2019 Hamburg, Germany An application will be made for accreditation to European

More information

Thomas C. Wilmot, Sr. Judy Wilmot Linehan

Thomas C. Wilmot, Sr. Judy Wilmot Linehan Thomas C. Wilmot, Sr. Judy Wilmot Linehan The Wilmot Family For more than 35 years, the Wilmot family has been dedicated to supporting cancer research and care for the Rochester community. Their generosity

More information

NOVEL MEDICATION FOR NEUROPATHIC PAIN

NOVEL MEDICATION FOR NEUROPATHIC PAIN NOVEL MEDICATION FOR NEUROPATHIC PAIN NRD.E1 a treatment for diabetic related neuropathic pain Novaremed s Dr Eli Kaplan shares research on NRD.E1 and explains how it can help to treat diabetic related

More information

CHAPTER GUIDELINES Contents: Updated: Fall 2017

CHAPTER GUIDELINES Contents: Updated: Fall 2017 CHAPTER GUIDELINES Contents: (click each section to be taken there) A B C D E F G What is a Chapter? Chapter Guidelines Chapter Structure Chapter Administration Chapter Activities & Annual Plans Opening

More information

Internet Society Philadelphia Chapter Meeting. 11 June 2010

Internet Society Philadelphia Chapter Meeting. 11 June 2010 Internet Society Philadelphia Chapter Meeting 11 June 2010 Who are we? Founded in 1992 by Internet Pioneers, as an international nonprofit organization 100+ organization members tens t of thousands of

More information

Quality standards for health and medical information on the Web

Quality standards for health and medical information on the Web Quality Online Medical and Health Information Quality standards for health and medical information on the Web Celia Boyer, celia.boyer@healthonnet.org Executive director Health On the Net Foundation www.healthonnet.org

More information

WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017

WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017 WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017 Mary L. Yost 404-520-6652 , LLC 23 Ridge Rd. Beaufort, SC 20097 Copyright Pending 2017 All rights reserved,

More information

MRCG Strategic Document

MRCG Strategic Document MRCG Strategic Document 2015-2016 The Medical Research Charities Group (MRCG) is an umbrella group of medical research and patient support charities that seeks to generate dynamic medical research in Ireland,

More information

Council of the European Union Brussels, 28 October 2015 (OR. en)

Council of the European Union Brussels, 28 October 2015 (OR. en) Conseil UE Council of the European Union Brussels, 28 October 2015 (OR. en) PUBLIC 13261/15 LIMITE SAN 347 NOTE From: To: Subject: General Secretariat of the Council Working Party on Public Health Draft

More information

Quality Indicators in Chronic Pain Management

Quality Indicators in Chronic Pain Management Disclosures (2008-2013): 1. Employment: Heidelberg University 2. Advisor: Allergan, Astellas, Astra-Zeneca, Boehringer Ingelheim, Galderma, Glaxo Smith Kline, Grünenthal, Lilly, Merz, Merck-Sharpe & Dohme,

More information

AUTISM SPEAKS RESOURCE IN PUBLIC HEALTH

AUTISM SPEAKS RESOURCE IN PUBLIC HEALTH AUTISM SPEAKS RESOURCE IN PUBLIC HEALTH Andy Shih, PhD Senior Vice President, Public Health & Inclusion Follow Me @ASAndyShih About Autism Speaks Mission Autism Speaks is dedicated to promoting solutions,

More information

Genetic and environmental risk factors for melanoma: translation into behavioural change

Genetic and environmental risk factors for melanoma: translation into behavioural change Genetic and environmental risk factors for melanoma: translation into behavioural change A Network of Excellence Project Funded by the EC Sixth Framework Programme PRIORITY 1 Life sciences, genomics and

More information

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal Public Health Public health is the science and art of preventing disease, prolonging

More information

Table Of Content. European Organisation for Rare Diseases... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs...

Table Of Content. European Organisation for Rare Diseases... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs... Table Of Content European Organisation for Rare Diseases... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs... 7 D04 - Electronic Newsletter (EN)... 7 D01 - Activity Report EURORDIS

More information

There is no shortage of housing problems - what is needed are solutions.

There is no shortage of housing problems - what is needed are solutions. There is no shortage of housing problems - what is needed are solutions. Peter Elderfield, founder, Building and Social Housing Foundation Rural Housing and Environment Programme, Gram Vikas - India. #40yearsBSHF

More information

Expanding the boundaries of nutrition Luis Cantarell

Expanding the boundaries of nutrition Luis Cantarell Expanding the boundaries of nutrition Luis Cantarell Nestlé Investor Seminar 30 September 2013 Disclaimer This presentation contains forward looking statements which reflect Management s current views

More information

A new weapon in the battle against cancer; Athens based Comprehensive Cancer Research Center

A new weapon in the battle against cancer; Athens based Comprehensive Cancer Research Center Under the Auspices of H.E. the President of the Hellenic Republic Mr. Prokopios Pavlopoulos A new weapon in the battle against cancer; Athens based Comprehensive Cancer Research Center The launch of the

More information

Innovation from the Foundation Sonya Dumanis, PhD

Innovation from the Foundation Sonya Dumanis, PhD Highlights in Research and Innovation from the Foundation Sonya Dumanis, PhD Senior Director of Innovation EPILEPSY FOUNDATION Our Mission: To lead the fight to overcome the challenges of living with epilepsy

More information

Susan G. Komen Central and Northern Arizona

Susan G. Komen Central and Northern Arizona Susan G. Komen Central and Northern Arizona Frank Nagy, Mission Director WHY IS EARLY DETECTION IMPORTANT? WHY IS EARLY DETECTION IMPORTANT? Regular screening tests (along with follow-up tests and treatment

More information

The European Reference Network in Rare Hematological Diseases

The European Reference Network in Rare Hematological Diseases The European Reference Network in Rare Hematological Diseases Pierre Fenaux ERN-EuroBloodNet coordinator www.eurobloodnet.eu The context of ERNs Share. Care. Cure. Due to the small patient number and the

More information

Nuclear accidents, environment and health in the post-fukushima era: emergency response

Nuclear accidents, environment and health in the post-fukushima era: emergency response 1 Recommendation 9235 Nuclear accidents, environment and health in the post-fukushima era: emergency response Seminar BVS-ABR Public Communication on Nuclear Emergencies Brussels, March 4, 2016 2 Overview

More information